| 763938 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
354 Lenvatinib and pembrolizumab in advanced endometrial carcinoma (EC): long-term efficacy and safety update from a phase 1b/2 study |
2021-11-01 |
10.1136/jitc-2021-sitc2021.354 |
Makker Vicky, Aghajanian Carol, Cohn Allen, Romeo Margarita, Bratos Raquel, Brose Marcia, Messing Mark, Dutta Lea, Dutcus Corina, Huang Jie, Schmidt Emmett, Orlowski Robert, Taylor Matthew |
| 763937 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
353 Identification of potential response predictors to maveropepimut-S (DPX-Survivac), a novel T cell activating immunotherapy, in patients with advanced recurrent ovarian cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.353 |
Dorigo Oliver, Ebrahimizadeh Walead, Kennedy Barry, MacDonald Lisa, Fiset Stephan, Villella Jeannine, Amit OZA, Pejovic Tanja, Ghatage Prafull, Ghamande Sharad, Provencher Diane, Bramhecha Yogesh |
| 763936 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
352 Target modulation within the tumor microenvironment (TME) by daratumumab (anti-CD38) but not edicotinib (CSF-1R inhibitor) in men with high-risk localized prostate cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.352 |
Siddiqui Bilal, Chapin Brian, Jindal Sonali, Duan Fei, Singh Shalini, Pettaway Curtis, Ward John, Tidwell Rebecca, Corn Paul, Logothetis Christopher, Allison James, Sharma Padmanee, Subudhi Sumit |
| 763935 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
350 Phase 2 trial of a DNA vaccine with pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC) |
2021-11-01 |
10.1136/jitc-2021-sitc2021.350 |
McNeel Douglas, Eickhoff Jens, Wargowski Ellen, Johnson Laura, Kyriakopoulos Christos, Emamekhoo Hamid, Lang Joshua, Brennan Mary Jane, Liu Glenn |
| 763934 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
397 A phase I/II trial of intracerebroventricular 177Lu DTPA omburtamab radioimmunotherapy for leptomeningeal metastasis from solid tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.397 |
Pentsova Elena, Düring Maria, Lind Charlotte Lybek, Nielsen John Rømer |
| 763933 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
393 A phase 1/2 study of SBT6050 combined with trastuzumab deruxtecan (T-DXd) or trastuzumab and tucatinib with or without capecitabine in patients with HER2-expressing or HER2-amplified cancers |
2021-11-01 |
10.1136/jitc-2021-sitc2021.393 |
Klempner Samuel, Strickler John, Gourley Lindsey, Jacquemont Celine, Bhatia Vinona, Hunder Naomi, Odegard Valerie, Piha-Paul Sarina |
| 763932 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
380 GS-3583, a novel FLT3 agonist Fc fusion protein, expands conventional dendritic cells in healthy volunteers |
2021-11-01 |
10.1136/jitc-2021-sitc2021.380 |
Rajakumaraswamy Nishanthan, Dauki Anees, Kuhne Michelle, Trowe Torsten, Weng Winnie, Lin Kai-Wen, Elboudjwarej Emon, Carr Brian, Worth Angela, Vashishtha Anshu, Schwabe Christian, Othman Ahmed |
| 763931 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
391 Biomarker correlates of response in patients with advanced myxoid/round cell liposarcoma (MRCLS) treated with NY-ESO-1 TCR T cells (Letetresgene autoleucel) |
2021-11-01 |
10.1136/jitc-2021-sitc2021.391 |
Kapoor Gurpreet, Zajic Stefan, Suchindran Sunil, Kim Jaegil, Eleftheriadou Ioanna, Huff Anne, Nathenson Michael, Druta Mihaela, Tine Brian Van, Somaiah Neeta, Liebner David, Schuetze Scott, D’Angelo Sandra |
| 763930 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
388 A trial to evaluate the safety, immunogenicity, and clinical activity of a helper peptide vaccine plus PD-1 blockade (Mel64, PATHVACS: PD-1 antibody and T-helper vaccine and correlative studies) |
2021-11-01 |
10.1136/jitc-2021-sitc2021.388 |
Slingluff Craig, Chianese-Bullock Kimberly, Mauldin Ileana, Olson Walter, Smith Kelly, Dengel Lynn, Haden Kathleen, Gaughan Elizabeth, Kaur Varinder, Grosh William |
| 763929 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
885 Targeting FPR2 as a novel approach for immunotherapy in pancreatic cancer female patients - studies of sexual immune dimorphism in the tumor microenvironment |
2021-11-01 |
10.1136/jitc-2021-sitc2021.885 |
Sarhan Dhifaf, He Fei, Calandigary Ahmed, Malki Enana, Fernández Moro Carlos, Kaisso Marina, Olofsson-Sahl Peter, Melssen Marit, Löhr Matthias, Karlsson Mikael, Heuchel Rainer |
